-
Capivasertib Extends Progression-Free Survival in Hormone Receptor-Positive Breast Cancer
The new AKT inhibitor doubled progression-free survival when added to treatment with Faslodex.
by Eric Fitzsimmons
-
Pregnancy After a Breast Cancer Diagnosis
Study finds pausing endocrine therapy is safe for early-stage breast cancer patients eager to expand their families.
by Thomas Celona
-
Disparities in Breast Cancer Outcomes for Black Women Despite Similar Recurrence Scores
Black breast cancer patients had worse outcomes in a recent study, even when cancer features aligned with white patients.
by Eric Fitzsimmons
Cancer Talk
Sex and Gender Minorities Face Disparities in Breast Cancer Care
Lesbians, bisexual women and transgender men had a longer wait for diagnosis and a higher risk of recurrence.
by Jon Kelvey
Deconstructing Peripheral Neuropathy and Chemo BrainResearchers explore mechanisms of chemotherapy-related neurotoxicity at the AACR Annual Meeting 2023.
by Marci A. Landsmann
AACR Annual Meeting 2023Catch up on all of Cancer Today's coverage from the AACR Annual Meeting 2023.
More Prostate Cancer Patients Choose SurveillanceMen are increasingly opting to put off treatment for low-risk prostate cancer, and doctors say it’s a good thing.
by Kyle Bagenstose